• Login
    View Item 
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Depressive Disorders
    • View Item
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Depressive Disorders
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Precision biomarkers for mood disorders based on brain imaging

    Thumbnail
    Date
    2020-10
    Author
    Capitao, Liliana
    Harmer, Catherine J
    Metadata
    Show full item record
    Citation
    Runsen Chen, Zaixu Cui, Liliana Capitão, Gang Wang, Theodore D Satterthwaite, Catherine Harmer. Precision biomarkers for mood disorders based on brain imaging. BMJ 2020;371:m3618
    Abstract
    Mood disorders are a global public health problem because of their high prevalence, chronicity, and recurrence throughout the lifespan as well as increased risk of mortality.123 They also impose a heavy economic burden on society because of lost work productivity (occupational disability) and increased use of health services.4 Early diagnosis and effective treatment are therefore essential. Mood disorders are characterised by a significant change in a person’s state of mood and include two main subtypes: depressive disorders (major depressive episode and dysthymia) and bipolar disorders (hypomania, mania, or cyclothymia—that is, cycling between depressed and manic states). In 2015, over 300 million people were living with major depressive disorder worldwide, representing 4.4% of the global population.5 A world mental health survey reported that the lifetime and 12 month prevalences of bipolar disorders in the general population were 2.4% and 1.5%, respectively.6 Mood disorders are associated with a widespread cognitive dysfunction, involving higher-order executive function,7 reward processing,8 and emotional regulation (fig 1, box 1).10 These deficits are associated with abnormalities in both the structure and function of specific brain circuits. Interest is growing in developing precision biomarkers for mood disorders based on a deeper understanding of their biological bases by integrating multilevels of data, such as brain imaging, clinical symptoms, and cognitive behaviours.1112
    URI
    https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/632
    Published online at:
    https://doi.org/10.1136/bmj.m3618
    Collections
    • Depressive Disorders [85]

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc
     

     

    Browse

    All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

    My Account

    Login

    Researcher Profiles

    Researchers

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc